Recently Updated
- 07/01/2011
- Map of Misoprostol Approval
- 06/02/2011
- Map of Mifepristone Approval
- 06/01/2011
- List of Mifepristone Approval
- 06/01/2011
- Misoprostol for Treatment of Postpartum Hemorrhage
- 11/26/2010
- Postpartum Hemorrhage Program Brief
Resources by Last Update
2011
July
June
Misoprostol for Treatment of Postpartum Hemorrhage
2010
November
Postpartum Hemorrhage Program Brief
2009
December
May
Medical Abortion Program Brief
Pregnancy Failure and Miscarriage Program Brief
March
Fever after treatment of postpartum hemorrhage
Blood Loss After Vaginal Delivery
Misoprostol for the Treatment of Postpartum Hemorrhage: Findings from Clinical Research Trials
2008
July
Annotated Bibliography - Misoprostol for Early Abortion
June
Reference List - Misoprostol for Incomplete Abortion and Miscarriage
Policy and Advocacy Activities Brief
Misoprostol for Incomplete Abortion and Miscarriage
Misoprostol for Early Abortion
Medical Abortion in the U.S.: Mifepristone Fact Sheet
Misoprostol in addition to routine treatment of postpartum hemorrhage in Pakistan
Treatment of incomplete abortion and miscarriage with misoprostol
Misoprostol to treat missed abortion in the first trimester
Supervision for use of mifepristone medical abortion
Misoprostol and Teratogenicity: Reviewing the Evidence
Misoprostol for Prevention of Postpartum Hemorrhage
PAC in Action Newsletter: Special Issue on Misoprostol in the PAC Context
Relationship of Hormonal Contraception to HIV
FAQ on Hormonal Contraception and HIV
Issue Brief on Hormonal Contraception and HIV
Outlook Newsletter on Hormonal Contraception and HIV
FAQs on Fatal Infection and Medical Abortion - Technical Version
FAQs on Fatal Infection and Medical Abortion - Summary
Misoprostol for Women’s Health
Route of Misoprostol Administration
Treatment of postpartum hemorrhage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Reproductive intentions among HIV-positive women and men
Misoprostol for incomplete abortion in Tanzania
Misoprostol for incomplete abortion in Burkina Faso
Perspectives on reproductive decision-making amongst HIV-infected individuals
Misoprostol for incomplete abortion in Mozambique
Mifepristone for late first trimester abortion
Can mifepristone medical abortion be simplified?
Are two doses of misoprostol after mifepristone for early abortion better than one?
Alternatives to mifepristone for early medical abortion
Use of sequential serum hCG and sonography for medical abortion only when indicated
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Materials Development Activities Brief
Social Science Research Activities Brief
Technical Assistance Activities Brief
Training and Education Activities Brief
Medical abortion: Outcomes in a family medicine setting
The Product Problem: Pathways for Making Misoprostol Available for Postpartum Hemorrhage
Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Expanding Choice in Abortion Services in Armenia
Two distinct oral routes of misoprostol in mifepristone medical abortion
Integrating medical abortion into safe abortion services in South Africa
Community-based kangaroo mother care to prevent neonatal and infant mortality
Clostridium sordellii infection in medical abortion
Regimens of misoprostol with mifepristone for early medical abortion
Abortion and sex determination
Improving Current Therapies and Exploring New Options in Abortifacient Technology
Mifepristone medical abortion in Albania
Sublingual misoprostol after mifepristone
Misoprostol for the Prevention of Postpartum Hemorrhage: Findings from Research in Pakistan
Sublingual misoprostol for incomplete abortion
Guidebook on Misoprostol for Treatment of Incomplete Abortion
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Comparison of serum markers for thrombophilia and autoimmune disease
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Acceptability and feasibility of medical abortion in Nepal
Annotated Bibliography - Mifepristone Medical Abortion
Home administration of misoprostol for early medical abortion in India
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
ICMA Third International Conference
Alternatives to Routine Follow-Up for Early Medical Abortion
High fever following postpartum administration of sublingual misoprostol
What measured blood loss tells us about postpartum bleeding
Misoprostol, Abortion, and the Law
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Misoprostol for PPH prevention in homebirths in Pakistan
Misoprostol to augment routine active management of the third stage of labor
Ultrasound for eligibility assessment for medical abortion
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Pericoital Oral Contraception with Levonorgestrel: A Systematic Review
Exploration of a new procedure for sterilization
Introduction and provision of medical abortion: A tale of two countries
Medical abortion for adolescents
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Abortion: What is the problem?
Misoprostol for Incomplete Abortion in Guatemala
Misoprostol for the prevention and treatment of postpartum hemorrhage
Misoprostol for postpartum hemorrhage: Moving from evidence to practice